This page does not represent the ACTREC institute officially. Please visit https://www.facebook.com/TMCACTREC for official updates. Information credit: https://en.wikipedia.org/wiki/Tata_Memorial_Centre
https://actrec.gov.in/
The Advanced Centre for Treatment, Research and Education in Cancer 'ACTREC' as it is called today, was originally established in 1952 as the Indian Cancer Research Centre (ICRC) and re-named Cancer Research Institute (CRI) in 1966. Khanolkar, then Director of Pathology and Biochemistry Laboratories, Tata Memorial Hospital (TMH). CRI was set up under the purview of the Ministry of Health, Government of India. In 1966, CRI was amalgamated with the Tata Memorial Hospital (TMH), creating the first comprehensive cancer centre in India - Tata Memorial Centre (TMC), a grant-in-aid institution of the Department of Atomic Energy (DAE), Government of India. In 2001, the CRI, moved to Navi Mumbai to become the basic research wing of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), and started functioning from its new premises from August 19, 2002. ACTREC comprises two wings: a basic research wing "Khanolkar Shodhika" and a clinical research wing "Paymaster Shodhika" (named after two visionary scientists of CRI). Research at ACTREC is broadly grouped under the following areas but not limited to: Biochemistry & Cell Biology, Chemical Carcinogenesis, Chemotherapy, Cancer Genomics, Genetic Engineering, Immunology, Neuro-oncology, Tobacco Carcinogenesis and Virology.
